norfloxacin has been researched along with Acute Disease in 53 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventy-three patients mainly receiving consolidation therapy for acute leukemia or autologous bone marrow transplantation were studied in a randomized trial comparing nystatin with norfloxacin (800 mg) given orally QID, for prevention of infection." | 9.07 | [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study]. ( Hattori, M; Maseki, N; Sampi, K, 1992) |
| "The bacteriologic and clinical efficacies of 3 days of lomefloxacin therapy were compared with those of 3 days of norfloxacin therapy for the treatment of acute uncomplicated urinary tract infections in a prospective, randomized, double-blind study." | 9.07 | Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. ( Conly, JM; DuBois, J; Harding, GK; Martel, AY; Nicolle, LE; Shafran, SD, 1993) |
| "To evaluate the clinical and microbiologic efficacy and safety of norfloxacin for acute diarrhea." | 9.07 | Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. ( Ekwall, E; Englund, G; Hogevik, H; Jertborn, M; Lagergren, L; Lundholm, R; Norlin, K; Söderquist, B; Strömberg, A; Wiström, J, 1992) |
| "The efficacy and safety of 7-10-day courses of lomefloxacin (single daily dose of 400 mg) or norfloxacin (twice-daily doses of 400 mg) for the treatment of uncomplicated urinary tract infections were compared in two large, multicenter, randomized trials." | 9.07 | Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults. ( Iravani, A, 1992) |
| "Thirty patients with acute urethritis were treated with short-term administration of norfloxacin." | 9.06 | [Clinical effectiveness of short-term administration of norfloxacin in acute urethritis]. ( Fukui, I; Goto, S; Kihara, K; Mizuo, T; Oshima, H, 1986) |
| "In a coordinated, double-blind multi-centre trial, adults with symptoms of acute pyelonephritis were randomly assigned to receive a two-week course of oral treatment with either 400 mg norfloxacin twice daily or 1 g cefadroxil twice daily." | 9.06 | Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. ( Englund, G; Lincoln, K; Nilsson, LG; Sandberg, T, 1990) |
| "Norfloxacin, an oral fluoroquinolone (dose 400 mg daily), was compared to a placebo in a double blinded randomized trial for the prophylaxis of travelers' diarrhea." | 9.06 | Norfloxacin for the prophylaxis of travelers' diarrhea in U.S. military personnel. ( Haberberger, RL; Hyams, KC; Scott, DA; Thornton, SA, 1990) |
| "We evaluated the effect of norfloxacin, 400 mg given orally every 12 hours, on the prevention of bacterial infections in 68 adult patients who had acute leukemia throughout prolonged courses of granulocytopenia (median, 32 days)." | 9.06 | Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. ( Bamberger, BJ; Bartlett, JG; Burke, PJ; Hendricksen, C; Karp, JE; Laughon, B; Merz, WG; Redden, T; Saral, R, 1987) |
| "Two-hundred nine patients with symptoms of acute urinary tract infection and pyuria were randomized to 400 mg of administered norfloxacin twice daily for three days, or 800 mg of sulfamethoxazole and 160 mg of trimethoprim administered twice daily for ten days." | 9.06 | A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. ( Boyko, EJ; Cox, CE; Goldstein, EJ; Kurtz, TO; Miller, K; Mummaw, N; Reller, LB; Stein, GE, 1987) |
| "A total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin (400 mg every 12 hours) or cotrimoxazole (160/800 mg every 12 hours) to prevent bacterial infection." | 9.06 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. ( Bow, EJ; Louie, TJ; Rayner, E, 1988) |
| "The efficacy and safety of Norfloxacin were studied in the treatment of 20 patients with acute epididymitis." | 9.06 | [Clinical study of norfloxacin in the treatment of acute epididymitis]. ( Arakawa, S; Fujii, A; Ka, S; Kamidono, S; Kawabata, G; Maeda, H; Matsumoto, O; Morishita, S; Takagi, S; Umezu, K, 1989) |
| "To objectively evaluate the efficacy, safety and utility of lomefloxacin (NY-198), a new quinolone antibacterial agent, in the treatment of acute uncomplicated cystitis, a comparative double blind trial was performed using norfloxacin (NFLX) as the control drug." | 9.06 | [A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis]. ( Amano, M; Arakawa, S; Fujita, Y; Ishigami, J; Kamidono, S; Kanemasa, Y; Kumon, H; Ohmori, H; Suzuki, K; Tanaka, H, 1989) |
| "Forty-three women with acute, symptomatic urinary tract infections were randomized to receive either norfloxacin (400 mg) twice daily or trimethoprim-sulfamethoxazole (160-800 mg) twice daily for 10 days." | 9.05 | Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. ( Haase, DA; Harding, GK; Kennedy, JK; Ronald, AR; Thomson, MJ; Urias, BA, 1984) |
| "Both norfloxacin and TMP/SMX were clinically effective in the treatment of travelers' diarrhea in this military population." | 6.67 | Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa. ( Batchelor, RA; Bourgeois, AL; Burr, DH; Gardiner, C; Garst, P; Hyams, KC; Kilpatrick, ME; Oprandy, JJ; Thornton, SA; Wignall, SF, 1992) |
| "Aerobic gram negative bacterial infections occur commonly in patients with acute leukemia undergoing intensive chemotherapy-induced bone marrow aplasia, and often arise from the gastrointestinal (GI) tract." | 6.66 | Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. ( Bamberger, BJ; Bartlett, JG; Burke, PJ; Hendricksen, C; Karp, JE; Laughon, B; Merz, WG; Redden, T; Saral, R, 1986) |
| "In a randomized study comparing cotrimoxazole plus colistin with ciprofloxacin, each in combination with nonabsorbable antimycotics, the incidence of major infections in terms of septicemias and pneumonias as well as of minor infections and episodes of unexplained fever (FUO) was higher in patients treated with ciprofloxacin." | 6.16 | Prevention of infection in acute leukemia. ( Daenen, S; de Pauw, BE; de Vries-Hospers, HG; Dekker, AW; Donnelly, JP; Gaus, W; Haralambie, E; Kern, W; Konrad, H; Maschmeyer, G, 1990) |
| "A retrospective study on the treatment of diarrhea in a U." | 5.28 | Treatment of acute diarrhea with norfloxacin during Desert Storm deployment. ( Johnson, GP; Ward, JE; Weston, TD, 1992) |
| "The bacteriologic and clinical efficacies of 3 days of lomefloxacin therapy were compared with those of 3 days of norfloxacin therapy for the treatment of acute uncomplicated urinary tract infections in a prospective, randomized, double-blind study." | 5.07 | Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. ( Conly, JM; DuBois, J; Harding, GK; Martel, AY; Nicolle, LE; Shafran, SD, 1993) |
| "A total of 125 ambulatory women (85 premenopausal and 40 postmenopausal) who experienced 174 acute urinary tract infections with mainly gram-negative bacteria (99%) was randomized to receive a single dose, 2-tablet treatment with either ofloxacin (400 mg." | 5.07 | Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. ( Pfau, A; Sacks, TG, 1993) |
| "To evaluate the clinical and microbiologic efficacy and safety of norfloxacin for acute diarrhea." | 5.07 | Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. ( Ekwall, E; Englund, G; Hogevik, H; Jertborn, M; Lagergren, L; Lundholm, R; Norlin, K; Söderquist, B; Strömberg, A; Wiström, J, 1992) |
| "Seventy-three patients mainly receiving consolidation therapy for acute leukemia or autologous bone marrow transplantation were studied in a randomized trial comparing nystatin with norfloxacin (800 mg) given orally QID, for prevention of infection." | 5.07 | [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study]. ( Hattori, M; Maseki, N; Sampi, K, 1992) |
| "Two hundred and forty-six patients with signs of acute bacterial conjunctivitis and/or blepharitis were randomised to receive either norfloxacin or chloramphenicol for one week in this double-masked parallel group study." | 5.07 | The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. ( Cook, T; Miller, IM; Vogel, R; Wittreich, JM, 1992) |
| "The efficacy and safety of 7-10-day courses of lomefloxacin (single daily dose of 400 mg) or norfloxacin (twice-daily doses of 400 mg) for the treatment of uncomplicated urinary tract infections were compared in two large, multicenter, randomized trials." | 5.07 | Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults. ( Iravani, A, 1992) |
| "Norfloxacin, an oral fluoroquinolone (dose 400 mg daily), was compared to a placebo in a double blinded randomized trial for the prophylaxis of travelers' diarrhea." | 5.06 | Norfloxacin for the prophylaxis of travelers' diarrhea in U.S. military personnel. ( Haberberger, RL; Hyams, KC; Scott, DA; Thornton, SA, 1990) |
| "In a coordinated, double-blind multi-centre trial, adults with symptoms of acute pyelonephritis were randomly assigned to receive a two-week course of oral treatment with either 400 mg norfloxacin twice daily or 1 g cefadroxil twice daily." | 5.06 | Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. ( Englund, G; Lincoln, K; Nilsson, LG; Sandberg, T, 1990) |
| "To objectively evaluate the efficacy, safety and utility of lomefloxacin (NY-198), a new quinolone antibacterial agent, in the treatment of acute uncomplicated cystitis, a comparative double blind trial was performed using norfloxacin (NFLX) as the control drug." | 5.06 | [A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis]. ( Amano, M; Arakawa, S; Fujita, Y; Ishigami, J; Kamidono, S; Kanemasa, Y; Kumon, H; Ohmori, H; Suzuki, K; Tanaka, H, 1989) |
| "The efficacy and safety of Norfloxacin were studied in the treatment of 20 patients with acute epididymitis." | 5.06 | [Clinical study of norfloxacin in the treatment of acute epididymitis]. ( Arakawa, S; Fujii, A; Ka, S; Kamidono, S; Kawabata, G; Maeda, H; Matsumoto, O; Morishita, S; Takagi, S; Umezu, K, 1989) |
| "A total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin (400 mg every 12 hours) or cotrimoxazole (160/800 mg every 12 hours) to prevent bacterial infection." | 5.06 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. ( Bow, EJ; Louie, TJ; Rayner, E, 1988) |
| "Two-hundred nine patients with symptoms of acute urinary tract infection and pyuria were randomized to 400 mg of administered norfloxacin twice daily for three days, or 800 mg of sulfamethoxazole and 160 mg of trimethoprim administered twice daily for ten days." | 5.06 | A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. ( Boyko, EJ; Cox, CE; Goldstein, EJ; Kurtz, TO; Miller, K; Mummaw, N; Reller, LB; Stein, GE, 1987) |
| "We evaluated the effect of norfloxacin, 400 mg given orally every 12 hours, on the prevention of bacterial infections in 68 adult patients who had acute leukemia throughout prolonged courses of granulocytopenia (median, 32 days)." | 5.06 | Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. ( Bamberger, BJ; Bartlett, JG; Burke, PJ; Hendricksen, C; Karp, JE; Laughon, B; Merz, WG; Redden, T; Saral, R, 1987) |
| "Thirty patients with acute urethritis were treated with short-term administration of norfloxacin." | 5.06 | [Clinical effectiveness of short-term administration of norfloxacin in acute urethritis]. ( Fukui, I; Goto, S; Kihara, K; Mizuo, T; Oshima, H, 1986) |
| "Forty-three women with acute, symptomatic urinary tract infections were randomized to receive either norfloxacin (400 mg) twice daily or trimethoprim-sulfamethoxazole (160-800 mg) twice daily for 10 days." | 5.05 | Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. ( Haase, DA; Harding, GK; Kennedy, JK; Ronald, AR; Thomson, MJ; Urias, BA, 1984) |
| "or t." | 3.76 | World-wide clinical experience with norfloxacin: efficacy and safety. ( Corrado, M; Hoagland, V; Sabbaj, J; Wang, C, 1986) |
| "To investigate the cost-effectiveness of two outpatient treatment strategies, TMP-SMX and norfloxacin, for acute uncomplicated pyelonephritis in adult women between the ages of 18 and 65 years." | 3.72 | A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women. ( Chen, SC; Chen, WJ; Davis, MA; Yen, ZS, 2003) |
| "The effect of a single day treatment with 600 mg norfloxacin 600 mg ofloxacin or 1,920 mg trimethoprim-sulfamethoxazol was determined on 114 patients with acute cystitis." | 3.67 | [Single day treatment in acute cystitis]. ( Kawaguchi, K; Yamaguchi, K, 1988) |
| " In addition, no severe adverse event was found in both groups." | 2.74 | Safety and efficacy of Qingre Buyi Decoction in the treatment of acute radiation proctitis: a prospective, randomized and controlled trial. ( Liu, JH; Tu, XH; Wang, L; Wang, Y; Zhang, ZZ; Zou, ZD, 2009) |
| "Both norfloxacin and TMP/SMX were clinically effective in the treatment of travelers' diarrhea in this military population." | 2.67 | Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa. ( Batchelor, RA; Bourgeois, AL; Burr, DH; Gardiner, C; Garst, P; Hyams, KC; Kilpatrick, ME; Oprandy, JJ; Thornton, SA; Wignall, SF, 1992) |
| "Aerobic gram negative bacterial infections occur commonly in patients with acute leukemia undergoing intensive chemotherapy-induced bone marrow aplasia, and often arise from the gastrointestinal (GI) tract." | 2.66 | Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. ( Bamberger, BJ; Bartlett, JG; Burke, PJ; Hendricksen, C; Karp, JE; Laughon, B; Merz, WG; Redden, T; Saral, R, 1986) |
| "Uncomplicated acute cystitis is one of the most common bacterial infections in adults." | 2.43 | Quinolones for uncomplicated acute cystitis in women. ( Andreeva, I; Rafalsky, V; Rjabkova, E, 2006) |
| "Rickettsial diseases such as murine typhus should be included in the differential diagnosis of otherwise healthy individuals who present with an acute systemic febrile illness and retinitis or neuroretinitis." | 2.40 | Retinal manifestations of acute murine typhus. ( Hudson, HL; Lopez, PF; Thach, AB, 1997) |
| "A retrospective study on the treatment of diarrhea in a U." | 1.28 | Treatment of acute diarrhea with norfloxacin during Desert Storm deployment. ( Johnson, GP; Ward, JE; Weston, TD, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (35.85) | 18.7374 |
| 1990's | 24 (45.28) | 18.2507 |
| 2000's | 7 (13.21) | 29.6817 |
| 2010's | 3 (5.66) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattrall, JWS | 1 |
| Robinson, AV | 1 |
| Kirby, A | 1 |
| Rocha, RM | 1 |
| Zanni, PC | 1 |
| de Souza Bonfim-Mendonça, P | 1 |
| Gimenes, F | 1 |
| Alczuk, SS | 1 |
| Svidzinski, TI | 1 |
| Consolaro, ME | 1 |
| Sharma, S | 1 |
| Srinivasaraghavan, R | 1 |
| Krishnamurthy, S | 1 |
| Wang, L | 1 |
| Zhang, ZZ | 1 |
| Tu, XH | 1 |
| Zou, ZD | 1 |
| Liu, JH | 1 |
| Wang, Y | 1 |
| Nicolle, LE | 3 |
| Madsen, KS | 1 |
| Debeeck, GO | 1 |
| Blochlinger, E | 1 |
| Borrild, N | 1 |
| Bru, JP | 1 |
| Mckinnon, C | 1 |
| O'Doherty, B | 1 |
| Spiegel, W | 1 |
| Van Balen, FA | 1 |
| Menday, P | 1 |
| Yen, ZS | 1 |
| Davis, MA | 1 |
| Chen, SC | 1 |
| Chen, WJ | 1 |
| Bassily, S | 1 |
| Mikhail, I | 1 |
| Haberberger, RL | 2 |
| Zakaria, S | 1 |
| Yassa, M | 1 |
| El Masry, NA | 1 |
| Woody, JN | 1 |
| Peppas, T | 1 |
| Petrikkos, G | 1 |
| Deliganni, V | 1 |
| Zoumboulis, P | 1 |
| Koulentianos, E | 1 |
| Giamarellou, H | 1 |
| Liso, V | 1 |
| Specchia, G | 1 |
| Pavone, V | 1 |
| Pansini, N | 1 |
| Capalbo, S | 1 |
| Ostuni, A | 1 |
| Mastria, A | 1 |
| Colucci, A | 1 |
| Costantino, G | 1 |
| Rafalsky, V | 1 |
| Andreeva, I | 1 |
| Rjabkova, E | 1 |
| Cuxart, M | 1 |
| Picazo, M | 1 |
| Sans, R | 1 |
| Muntané, MJ | 1 |
| Deaney, NB | 1 |
| Vogel, R | 2 |
| Vandenburg, MJ | 1 |
| Currie, WJ | 1 |
| Reeves, DS | 1 |
| Lacey, RW | 1 |
| Mummery, RV | 1 |
| Mahendra, M | 1 |
| Bint, AJ | 1 |
| Newsom, SW | 1 |
| Haase, DA | 1 |
| Harding, GK | 2 |
| Thomson, MJ | 1 |
| Kennedy, JK | 1 |
| Urias, BA | 1 |
| Ronald, AR | 1 |
| DuBois, J | 1 |
| Martel, AY | 1 |
| Shafran, SD | 1 |
| Conly, JM | 1 |
| Pfau, A | 1 |
| Sacks, TG | 1 |
| Trienekens, TA | 1 |
| London, NH | 1 |
| Houben, AW | 1 |
| De Jong, RA | 1 |
| Stobberingh, EE | 1 |
| Guibert, J | 1 |
| Mazeman, E | 1 |
| Colau, JC | 1 |
| Delavault, P | 1 |
| Pitkäjärvi, T | 1 |
| Kujanne, E | 1 |
| Sillantaka, I | 1 |
| Lumio, J | 1 |
| Carratala, J | 1 |
| Fernandez-Sevilla, A | 1 |
| Tubau, F | 1 |
| Dominguez, MA | 1 |
| Gudiol, F | 1 |
| Rataboli, PV | 1 |
| D'Souza, RS | 1 |
| Dhume, VG | 1 |
| Levadoux, M | 1 |
| Carli, P | 1 |
| Gadea, JF | 1 |
| De Mauleon De Bruyere, P | 1 |
| Perre, C | 1 |
| Hudson, HL | 1 |
| Thach, AB | 1 |
| Lopez, PF | 1 |
| Caron, F | 1 |
| Moolasart, P | 1 |
| Eampokalap, B | 1 |
| Ratanasrithong, M | 1 |
| Cronberg, S | 1 |
| Banke, S | 1 |
| Bergman, B | 1 |
| Boman, H | 1 |
| Eilard, T | 1 |
| Elbel, E | 1 |
| Hugo-Persson, M | 1 |
| Johansson, E | 1 |
| Kuylenstierna, N | 1 |
| Lanbeck, P | 1 |
| Lindblom, A | 1 |
| Paulsen, O | 1 |
| Schönbeck, C | 1 |
| Walder, M | 1 |
| Wieslander, P | 1 |
| Drabo, YJ | 1 |
| Niakara, A | 1 |
| Ouedraogo, H | 1 |
| Iravani, A | 1 |
| Miller, IM | 1 |
| Wittreich, JM | 1 |
| Cook, T | 1 |
| Johnson, GP | 1 |
| Weston, TD | 1 |
| Ward, JE | 1 |
| Saginur, R | 1 |
| Thornton, SA | 2 |
| Wignall, SF | 1 |
| Kilpatrick, ME | 1 |
| Bourgeois, AL | 1 |
| Gardiner, C | 1 |
| Batchelor, RA | 1 |
| Burr, DH | 1 |
| Oprandy, JJ | 1 |
| Garst, P | 1 |
| Hyams, KC | 2 |
| Sampi, K | 1 |
| Maseki, N | 1 |
| Hattori, M | 1 |
| Wiström, J | 1 |
| Jertborn, M | 1 |
| Ekwall, E | 1 |
| Norlin, K | 1 |
| Söderquist, B | 1 |
| Strömberg, A | 1 |
| Lundholm, R | 1 |
| Hogevik, H | 1 |
| Lagergren, L | 1 |
| Englund, G | 2 |
| Wang, XF | 1 |
| Jiang, SC | 1 |
| Wei, YL | 1 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| de Pauw, BE | 1 |
| de Vries-Hospers, HG | 1 |
| Dekker, AW | 1 |
| Donnelly, JP | 1 |
| Gaus, W | 1 |
| Haralambie, E | 1 |
| Kern, W | 1 |
| Konrad, H | 1 |
| Aragonés, E | 1 |
| Torres, M | 1 |
| Sarrà, N | 1 |
| Martí, R | 1 |
| Scott, DA | 1 |
| Sandberg, T | 1 |
| Lincoln, K | 1 |
| Nilsson, LG | 1 |
| Morita, H | 1 |
| Tomoda, T | 1 |
| Araki, K | 1 |
| Kurashige, T | 1 |
| Nishibayashi, Y | 1 |
| Matsumoto, K | 1 |
| Zushi, N | 1 |
| Ohmori, H | 1 |
| Kumon, H | 1 |
| Suzuki, K | 1 |
| Kamidono, S | 2 |
| Arakawa, S | 2 |
| Ishigami, J | 1 |
| Tanaka, H | 1 |
| Amano, M | 1 |
| Fujita, Y | 1 |
| Kanemasa, Y | 1 |
| Takagi, S | 1 |
| Maeda, H | 1 |
| Ka, S | 1 |
| Matsumoto, O | 1 |
| Umezu, K | 1 |
| Kawabata, G | 1 |
| Fujii, A | 1 |
| Morishita, S | 1 |
| Yamaguchi, K | 1 |
| Kawaguchi, K | 1 |
| Lolekha, S | 1 |
| Patanachareon, S | 1 |
| Thanangkul, B | 1 |
| Vibulbandhitkit, S | 1 |
| Aoki, T | 1 |
| Shimizu, N | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Matsubara, Y | 1 |
| Seo, T | 1 |
| Sagara, H | 1 |
| Tagawa, K | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Bow, EJ | 1 |
| Rayner, E | 1 |
| Louie, TJ | 1 |
| Dupont, HL | 1 |
| Corrado, ML | 1 |
| Sabbaj, J | 2 |
| Stein, GE | 1 |
| Mummaw, N | 1 |
| Goldstein, EJ | 1 |
| Boyko, EJ | 1 |
| Reller, LB | 1 |
| Kurtz, TO | 1 |
| Miller, K | 1 |
| Cox, CE | 1 |
| Karp, JE | 2 |
| Merz, WG | 2 |
| Hendricksen, C | 2 |
| Laughon, B | 2 |
| Redden, T | 2 |
| Bamberger, BJ | 2 |
| Bartlett, JG | 2 |
| Saral, R | 2 |
| Burke, PJ | 2 |
| Wang, C | 1 |
| Corrado, M | 1 |
| Hoagland, V | 1 |
| Gallego Gómez, J | 1 |
| Llopis Mínguez, B | 1 |
| Boronat Tormo, F | 1 |
| Martínez García, R | 1 |
| Oliver Amorós, F | 1 |
| Gobernado Serrano, M | 1 |
| Jiménez Cruz, JF | 1 |
| Kihara, K | 1 |
| Mizuo, T | 1 |
| Fukui, I | 1 |
| Oshima, H | 1 |
| Goto, S | 1 |
6 reviews available for norfloxacin and Acute Disease
| Article | Year |
|---|---|
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Comb | 2018 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolo | 2006 |
Retinal manifestations of acute murine typhus.
Topics: Acute Disease; Adult; Antibodies, Bacterial; Diagnosis, Differential; Doxycycline; Eye Infections, B | 1997 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil | 1998 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
World-wide clinical experience with norfloxacin: efficacy and safety.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Gastroente | 1986 |
31 trials available for norfloxacin and Acute Disease
| Article | Year |
|---|---|
Safety and efficacy of Qingre Buyi Decoction in the treatment of acute radiation proctitis: a prospective, randomized and controlled trial.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Azulenes; Drug Therapy, Combination; Drugs, Ch | 2009 |
Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.
Topics: Acute Disease; Adult; Aged; Amdinocillin Pivoxil; Anti-Infective Agents; Double-Blind Method; Female | 2002 |
Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents, Urinary; Citrates; Citric Acid; Clinical Tr | 1984 |
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Feces; Fema | 1984 |
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Canada; Double-Blind Method; Female; | 1993 |
Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Gram-Negative Bacterial Infect | 1993 |
Treating acute urinary tract infections. An RCT of 3-day versus 7-day norfloxacin.
Topics: Absenteeism; Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Escherichia coli Infection | 1993 |
[Acute cystitis in women over 50 years of age. Efficacy of pefloxacin with single dose and norfloxacin for 10 days].
Topics: Acute Disease; Administration, Oral; Aged; Cystitis; Drug Evaluation; Drug Therapy, Combination; Fem | 1993 |
Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Carrier State; Double-Blind Method; F | 1996 |
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
Topics: Acute Disease; Anti-Infective Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Diarrhea; | 1999 |
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftibut | 2001 |
Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Administratio | 1992 |
The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Blepharitis; Child; Child, Preschool; Chl | 1992 |
Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group.
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration | 1992 |
Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa.
Topics: Acute Disease; Adolescent; Adult; Africa, Western; Bacterial Infections; Diarrhea; Escherichia coli | 1992 |
[A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bacterial Infections; Bone Marrow Transplant | 1992 |
Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Diarrhea; Double-Blind Method; Fem | 1992 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
Norfloxacin for the prophylaxis of travelers' diarrhea in U.S. military personnel.
Topics: Acute Disease; Adult; Developing Countries; Diarrhea; Egypt; Follow-Up Studies; Humans; Military Per | 1990 |
Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacteriuria; Cefadroxil; Chi-Square Distr | 1990 |
[A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Child; Clinical Trials as T | 1989 |
[Clinical study of norfloxacin in the treatment of acute epididymitis].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bacterial Infections; Clinical Trials as Topic; Epidi | 1989 |
Norfloxacin versus co-trimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study.
Topics: Acute Disease; Adult; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Double-Blind Method; | 1988 |
Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; Drug Co | 1988 |
Use of norfloxacin in the treatment of acute diarrheal disease.
Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Diarrhea; Drug Combinations; Feces; Humans; M | 1987 |
A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Administra | 1987 |
Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Agranulocytosis; Bacterial Infections; Clinical Tr | 1986 |
World-wide clinical experience with norfloxacin: efficacy and safety.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Gastroente | 1986 |
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Agents | 1987 |
[Norfloxacin versus pipemidic acid in acute cystitis].
Topics: Acute Disease; Cystitis; Female; Humans; Nicotinic Acids; Norfloxacin; Pipemidic Acid | 1987 |
[Clinical effectiveness of short-term administration of norfloxacin in acute urethritis].
Topics: Acute Disease; Adult; Drug Administration Schedule; Gonorrhea; Humans; Male; Middle Aged; Norfloxaci | 1986 |
18 other studies available for norfloxacin and Acute Disease
| Article | Year |
|---|---|
Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Brazil; Candida; Candidiasis, Vulvovaginal; | 2016 |
Central Nervous System Symptoms Due to Transient Methemoglobinemia in a Child With G6PD Deficiency.
Topics: Acute Disease; Child, Preschool; Consanguinity; Cyanosis; Glucosephosphate Dehydrogenase Deficiency; | 2017 |
A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Cost- | 2003 |
The use of quinolones in the treatment of acute bacterial diarrhea: a comparative therapeutic trial.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Bacteria; Bacterial Infections; Chloramphenicol; D | 1989 |
Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Humans; Male; Mi | 1989 |
Prophylactic administration of oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemias.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Agents | 1989 |
[Norfloxacin-induced acute interstitial nephritis].
Topics: Acute Disease; Aged; Fluoroquinolones; Humans; Male; Nephritis, Interstitial; Norfloxacin | 2007 |
Norfloxacin in acute urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacteriuria; Child; Female; | 1984 |
Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; DNA, Bacterial; Drug Resistance, Micr | 1996 |
An unusual hallucination with norfloxacin.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Dysentery, Bacillary; Female; Hallucinations; Huma | 1996 |
[Repeated rupture of the extensor tendons of the hand due to fluoroquinolones. Apropos of a case].
Topics: Acute Disease; Aged; Anti-Infective Agents; Blood Vessels; Chronic Disease; Female; Hand; Hemosidero | 1997 |
[Acute pancreatitis secondary to administration or norfloxacin].
Topics: Acute Disease; Anti-Infective Agents; Humans; Male; Middle Aged; Norfloxacin; Pancreatic Function Te | 2002 |
Treatment of acute diarrhea with norfloxacin during Desert Storm deployment.
Topics: Acute Disease; Adult; Diarrhea; Egypt; Female; Humans; Male; Military Personnel; Norfloxacin; Retros | 1992 |
[Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
Topics: Acute Disease; Dysentery, Bacillary; Enoxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Shi | 1990 |
[Single dose in therapeutic strategy in acute urinary tract infection].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Female; Humans; Norfloxacin; Time Factors; Trimet | 1990 |
[Clinical efficacy and safety of norfloxacin tablets in pediatrics].
Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Bronchitis; Child; Child, Preschool; D | 1990 |
[Single day treatment in acute cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cystitis; | 1988 |
[Clinical study of AM-715 on acute infectious enteritis. The Japan Research Committee of AM-715, Research Group for Acute Infectious Enteritis].
Topics: Acute Disease; Administration, Oral; Campylobacter Infections; Drug Administration Schedule; Dysente | 1986 |